Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI
Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron.
Related Articles
Words of Wisdom for Early-Career Interventional Cardiologists
The inaugural generation of ICs urge humility, common sense, knowing your limits, and avoiding shortcuts.
High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants
The findings highlight the need to both ensure adherence to anticoagulation and control other risk factors.
Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says
Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.
JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines
The aim is to “activate these guidelines in a way that they become more actionable for clinicians,” Harlan Krumholz says.
Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL
The lack of effect shouldn’t detract from MINT, which showed a strong trend toward benefit with liberal blood transfusion.
Pressure-Based Physiological Testing Results Diverge Between LAD, LCx
Relying on iFR/FFR values from the LCx alone could mean many patients with left main disease miss out on revascularization.
EMS Practices for OHCA Diverge Between Black/Hispanic, White Areas
This explains at least some of the racial/ethnic gaps in survival, researchers say. Harder to pinpoint is exactly why practices differ.
Rising Cardiac Mortality Since the COVID Era Raises Questions About Healthcare Delivery
With new CVD treatments arriving each year, “there’s no reason why outcomes should be getting worse,” says Jason Wasfy.
Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION
Nearly two-thirds of patients reached < 70 mg/dL with the small interfering RNA therapy.